Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Yadav A, Malik PS, Khurana S. et al.
An open-label randomized controlled trial comparing the efficacy and safety of pemetrexed-carboplatin versus (weekly) paclitaxel-carboplatin as first-line chemotherapy in advanced non-squamous non-small cell lung cancer.

Oncology 2021;
99 (06) 389-396

Bibliographische Angaben herunterladen

Aufrufen in: